Advanced in Brain Tumor

Laetitia Padovani

264 Rue Saint Pierre, 
Marseille, FR 
Advanced in Brain Tumor
264 Rue Saint Pierre, 
Marseille, FR 
OverviewLocationsClinical Research

Overview

Laetitia Padovani practices in Marseille, France. Ms. Padovani is rated as an Advanced expert by MediFind in the treatment of Brain Tumor. Her top areas of expertise are Medulloblastoma, Dysembryoplastic Neuroepithelial Tumors (DNET), Embryonal Tumor with Multilayered Rosettes, and Gliomatosis Cerebri.

Her clinical research consists of co-authoring 91 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 43 articles and participated in 1 clinical trial in the study of Brain Tumor.

Gender
Female

Locations

264 Rue Saint Pierre, Marseille, 13005, France
Other Locations
Aix-en-provence, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Hypofractionated Stereotactic Radiation Treatments (SBRT) on Children, Teenagers and Young Adults Malignant Tumors
Hypofractionated Stereotactic Radiation Treatments (SBRT) on Children, Teenagers and Young Adults Malignant Tumors
Enrollment Status: Completed
Publish Date: March 08, 2022
Intervention Type: Radiation
Study Phase: Not Applicable
Phase III Randomized Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma : Standard 3D Conformational Radiotherapy Versus Intensity-modulated Radiotherapy With Simultaneous-integrated Boost Guided by Magnetic Resonance Spectroscopic Imaging
Phase III Randomized Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma : Standard 3D Conformational Radiotherapy Versus Intensity-modulated Radiotherapy With Simultaneous-integrated Boost Guided by Magnetic Resonance Spectroscopic Imaging
Enrollment Status: Terminated
Publish Date: January 12, 2021
Intervention Type: Radiation
Study Phase: Phase 3
View 1 Less Clinical Trial

91 Total Publications

Autonomy duration in patients with biopsy-only unresectable IDH wild-type glioblastomas.
Autonomy duration in patients with biopsy-only unresectable IDH wild-type glioblastomas.
Journal: Journal of neuro-oncology
Published: August 26, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Padovani's expertise for a condition
ConditionClose
    View All 20 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile